Standalone Q2 revenue rises 208% and profit rises 195%

Revenue Growth 20pctPat Growth 25pctEbitda Margin CompressionResults RestatedResults View source PDF Explain this filing

ANURAS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-4.0%Reaction day

₹1124.90

prior close

₹1145.90

announcement price

In-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)-0.2%-3.8% vs market

Specialty Chemicals peers, median of 82sector-0.6%-3.4% vs sector

On the reaction day the stock moved 3.8 pts less than Nifty Smallcap 250 and 3.4 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.3

10m

-2.5

15m

-2.3

30m

-3.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-4.0-0.2-3.8-0.6-3.4

Next day

-4.3+0.3-4.6-0.8-3.5

-2.5+1.0-3.5+0.6-3.1

-3.8+0.7-4.6-0.0-3.8

-2.7+0.6-3.3+0.0-2.7

-2.8+1.2-4.1-1.0-1.8

-3.0+1.8-4.8-0.5-2.4

15d

-5.1-0.7-4.4-4.1-1.1

-3.5+0.5-4.0-4.2+0.7

+17.7-5.3+23.0-9.9+27.6

+15.1-6.4+21.5-14.9+30.0

UpDownMarket · Nifty Smallcap 250Sector · Specialty Chemicals peers, median of 82Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The board approved unaudited standalone and consolidated results for Q2 and the half year ended September 30, 2025. Standalone Q2 revenue rose 208% to INR 5,879.26 million and profit after tax rose 195% to INR 413.99 million. Half-year revenue rose 155% and profit after tax rose 360%. Consolidated owners' profit rose 166% for Q2 and 281% for the half year, reaching INR 443.93 million and INR 784.30 million. The auditor's review found no issue.

Likely market impact

Strong revenue and profit growth may support the stock, while higher finance costs and lower operating margins are risks.